These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 21053143

  • 1. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.
    Andaloussi SE, Lehto T, Lundin P, Langel U.
    Methods Mol Biol; 2011; 683():361-73. PubMed ID: 21053143
    [Abstract] [Full Text] [Related]

  • 2. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
    Guterstam P, Andaloussi SE, Langel U.
    Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
    [Abstract] [Full Text] [Related]

  • 3. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
    Hassane FS, Abes R, El Andaloussi S, Lehto T, Sillard R, Langel U, Lebleu B.
    J Control Release; 2011 Jul 30; 153(2):163-72. PubMed ID: 21536086
    [Abstract] [Full Text] [Related]

  • 4. A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy.
    Mäe M, El Andaloussi S, Lundin P, Oskolkov N, Johansson HJ, Guterstam P, Langel U.
    J Control Release; 2009 Mar 19; 134(3):221-7. PubMed ID: 19105971
    [Abstract] [Full Text] [Related]

  • 5. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
    Shiraishi T, Nielsen PE.
    Methods Mol Biol; 2011 Mar 19; 683():391-7. PubMed ID: 21053145
    [Abstract] [Full Text] [Related]

  • 6. Induction of splice correction by cell-penetrating peptide nucleic acids.
    El-Andaloussi S, Johansson HJ, Lundberg P, Langel U.
    J Gene Med; 2006 Oct 19; 8(10):1262-73. PubMed ID: 16900561
    [Abstract] [Full Text] [Related]

  • 7. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
    Shiraishi T, Nielsen PE.
    Methods Mol Biol; 2011 Oct 19; 751():209-21. PubMed ID: 21674333
    [Abstract] [Full Text] [Related]

  • 8. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy.
    Lehto T, Abes R, Oskolkov N, Suhorutsenko J, Copolovici DM, Mäger I, Viola JR, Simonson OE, Ezzat K, Guterstam P, Eriste E, Smith CI, Lebleu B, Samir El Andaloussi, Langel U.
    J Control Release; 2010 Jan 04; 141(1):42-51. PubMed ID: 19744531
    [Abstract] [Full Text] [Related]

  • 9. Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides.
    El Andaloussi S, Said Hassane F, Boisguerin P, Sillard R, Langel U, Lebleu B.
    Methods Mol Biol; 2011 Jan 04; 764():75-89. PubMed ID: 21748634
    [Abstract] [Full Text] [Related]

  • 10. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J, Neundorf I.
    Acc Chem Res; 2012 Jul 17; 45(7):1048-56. PubMed ID: 22455499
    [Abstract] [Full Text] [Related]

  • 11. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L, Morris MC, Heitz F, Divita G.
    Methods Mol Biol; 2011 Jul 17; 764():59-73. PubMed ID: 21748633
    [Abstract] [Full Text] [Related]

  • 12. Peptide nanoparticles for oligonucleotide delivery.
    Lehto T, Ezzat K, Langel U.
    Prog Mol Biol Transl Sci; 2011 Jul 17; 104():397-426. PubMed ID: 22093225
    [Abstract] [Full Text] [Related]

  • 13. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L, Divita G.
    Methods Mol Biol; 2011 Jul 17; 683():349-60. PubMed ID: 21053142
    [Abstract] [Full Text] [Related]

  • 14. A non-covalent strategy combining cationic lipids and CPPs to enhance the delivery of splice correcting oligonucleotides.
    Trabulo S, Resina S, Simões S, Lebleu B, Pedroso de Lima MC.
    J Control Release; 2010 Jul 14; 145(2):149-58. PubMed ID: 20362021
    [Abstract] [Full Text] [Related]

  • 15. Distinct uptake routes of cell-penetrating peptide conjugates.
    Lundin P, Johansson H, Guterstam P, Holm T, Hansen M, Langel U, EL Andaloussi S.
    Bioconjug Chem; 2008 Dec 14; 19(12):2535-42. PubMed ID: 19012426
    [Abstract] [Full Text] [Related]

  • 16. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
    Abes S, Moulton HM, Clair P, Prevot P, Youngblood DS, Wu RP, Iversen PL, Lebleu B.
    J Control Release; 2006 Dec 01; 116(3):304-13. PubMed ID: 17097177
    [Abstract] [Full Text] [Related]

  • 17. PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors.
    Lindberg S, Muñoz-Alarcón A, Helmfors H, Mosqueira D, Gyllborg D, Tudoran O, Langel U.
    Int J Pharm; 2013 Jan 30; 441(1-2):242-7. PubMed ID: 23200958
    [Abstract] [Full Text] [Related]

  • 18. Assessing the delivery efficacy and internalization route of cell-penetrating peptides.
    El Andaloussi S, Guterstam P, Langel U.
    Nat Protoc; 2007 Jan 30; 2(8):2043-7. PubMed ID: 17703217
    [Abstract] [Full Text] [Related]

  • 19. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I, Akita H, Kogure K, Gräslund A, Langel U, Harashima H, Futaki S.
    Acc Chem Res; 2012 Jul 17; 45(7):1132-9. PubMed ID: 22208383
    [Abstract] [Full Text] [Related]

  • 20. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS, Hatlevig SA, Hassinger JN, Iversen PL, Moulton HM.
    Bioconjug Chem; 2007 Jul 17; 18(1):50-60. PubMed ID: 17226957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.